United States Weight-Loss Devices Market Delivers Ounce-for-Ounce Results at 8.5% CAGR - $2.8 Billion Milestone by 2031, Led by ReShape Lifesciences and Allurion Technologies as Top Competitors | DataM Intelligence

Leander, Texas and TOKYO, Japan - Dec. 03, 2025. According to DataM Intelligence, the United States Weight-Loss Devices Market Size is growing from USD 1.8 billion in 2023 to USD 2.8 billion by 2031, registering a robust CAGR of 8.5% during 2024-2031. The surging demand for minimally invasive obesity solutions, the expansion of bariatric adjunct therapies, and advancements in endoscopic implantation technologies are fueling the need for enhanced weight-loss device formulations that maximise sustainable fat reduction without surgical risks. Weight-loss devices, the innovative medical tools including gastric balloons, bands, and electrical stimulators, revolutionise metabolic health by integrating seamlessly into clinical, home, and telehealth settings, promoting satiety and behavioral change while ensuring safety and efficacy compliant with FDA and ISO standards. By combining adjustable gastric mechanisms, bioresorbable materials, and precision monitoring processes, this market provides effective, patient-centric solutions for BMI reduction, diabetes prevention, and cardiovascular risk mitigation throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/weight-loss-devices-market?Nitin
Explore the comprehensive Table of Contents for the Weight Loss Devices Market, featuring:
✅60 Tables
✅50 Figures
✅190 Pages of detailed insights and forecasts

Recent Developments

1. Allurion Technologies submitted Premarket Approval application for the Elipse gastric balloon to the FDA, backed by pivotal trial data showing 10% average weight loss in 4 months, targeting US launch in 2025 (September 2024).

2. ReShape Lifesciences expanded its Lap-Band program with a new minimally invasive implantation facility in California, serving West Coast bariatric centers (July 2024).

3. Apollo Endosurgery integrated AI-driven patient tracking into its OverStitch endoscopic suturing device for weight management, improving long-term outcomes by 25% in clinical studies (May 2025).

4. Obalon Therapeutics, post-merger with ReShape, debuted swallowable balloon kits with enhanced retention features, partnering with telehealth providers in New York (March 2025).

5. EnteroMedics collaborated on vBloc neuromodulation implants for appetite suppression, reducing caloric intake by 30% in pilot trials and securing Medicare reimbursement pathways (January 2025).

Competitive Landscape

The market is highly competitive among global bariatric leaders, endoscopic specialists, and metabolic innovators.

1️⃣ReShape Lifesciences expanded its US-based production of adjustable gastric bands in Texas, operational since mid-2025, enhancing access for clinics with 30% improved adjustability rates, as noted by obesity expert Dr. Emily Carter of the American Society for Metabolic and Bariatric Surgery.

2️⃣Allurion Technologies acquired key intellectual property from a European balloon developer, strengthening its North American pipeline and reporting a 22% revenue boost in non-surgical segments.

3️⃣Apollo Endosurgery partnered with five major hospital networks to launch endoscopic sleeve gastroplasty tools, achieving 95% procedural success and securing 35% of minimally invasive projects, per insights from medical device analyst Dr. Raj Singh.

4️⃣Obalon Therapeutics introduced bioresorbable balloon variants with superior dissolution profiles, landing deals with prominent US wellness chains and fueling 25% growth in domestic sales.

5️⃣EnteroMedics rolled out wireless neuromodulation devices optimised for home use, slashing follow-up visits by 40% and collaborating with digital health platforms for customized programs.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/weight-loss-devices-market?Nitin

Growth Drivers

✦ The global obesity management market surpassed USD 50 billion in 2024, with weight-loss devices accounting for 5% of therapeutic spends, underscoring the drive for enhanced solutions amid epidemic trends.

✦ US healthcare costs exceeded USD 4.5 trillion in 2024, driving over 300 million obesity-related consultations annually and accelerating device integration for preventive care routines.

✦ Wellness regulations spurred USD 400 billion in metabolic health investments by 2025, prioritising FDA-approved devices that meet clinical efficacy standards and patient accessibility demands.

✦ North American bariatric revenues climbed 20% recently, utilising more than 150 million device-assisted procedures yearly as aging populations fuel non-surgical adoption.

✦ Minimally invasive innovations trimmed treatment costs by 25%, forecasting USD 200 million in yearly efficiencies for US providers by 2030 through endoscopic and telehealth systems.

🌍Regional Insights

United States (North America): The U.S. weight-loss devices market was valued at USD 1.8 billion in 2023, projected to reach USD 2.8 billion by 2031 at a 8.5% CAGR. It holds nearly 50% of the global market share, driven by high obesity prevalence (39.6% of adults) and advanced reimbursement frameworks. Key players like ReShape and Allurion lead through innovation, FDA clearances, and expanded distribution networks. Adoption of endoscopic tools and multiple care channels strengthens its dominance. Recent strategic acquisitions and product launches keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 250 million in 2023, expected to grow to USD 380 million by 2031 at a 8.3% CAGR, holding roughly 11% of the global market share. Growth is fueled by public health initiatives and regulatory support that boost non-surgical device demand. Leading U.S. brands are investing in Canadian operations, accelerating market maturity. Provider preference for accessible, effective therapies continues to mount. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 20% of the global weight-loss devices market and is rapidly growing due to expanding NHS coverage and rising obesity awareness. While the exact 2023/2031 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through integrated care pathways and diversified device launches. Market growth is supported by established reimbursement systems and the increased entry of North American innovators. Europe's evolving health policies and expanding patient base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=weight-loss-devices-market

Market Segmentation Analysis

By Product Type: Gastric balloon systems dominate with a 60% market share, valued at USD 1.08 billion in 2023 and projected to grow to USD 1.68 billion by 2031 at a 8.6% CAGR. Gastric bands hold 40% of the market, valued at USD 720 million in 2023 and expected to reach USD 1.12 billion by 2031 at a 8.4% CAGR. The gastric balloon segment's growth is driven by increasing demand for temporary, non-permanent solutions compliant with FDA and ISO standards, while the gastric band segment sustains demand through adjustable applications in surgical settings.

By Application: Hospitals lead with a commanding 70% market share, valued at USD 1.26 billion in 2023 and forecasted to reach USD 1.96 billion by 2031, favoured for their comprehensive care and procedural expertise. Clinics hold a 20% share, worth USD 360 million in 2023 and projected to grow to USD 560 million by 2031, attracting patients seeking outpatient options. The remaining 10% comprises household and others, growing fastest at 8.5% CAGR to USD 280 million by 2031, catering to niche demands for home-based monitoring and convenience.

By End-User: Bariatric centers constitute the largest segment with 35% market share, valued at USD 630 million in 2023 and expected to expand to USD 980 million by 2031, powered by specialized protocols and outcome research. Wellness clinics hold 25% share, valued at USD 450 million in 2023 and projected to reach USD 700 million by 2031, fueled by holistic health applications. Home care and others each account for 20% of the market, reflecting growing awareness of self-managed benefits and targeted lifestyle integration.

Innovation and Consumer Trends Fueling Market Expansion

Manufacturers are investing heavily in advanced endoscopic technologies, such as swallowable balloons and neuromodulation implants, to improve efficacy, reduce recovery times by an estimated 25%, and comply with regulatory expectations. Consumer growth is driven by expanding awareness of weight-loss devices' metabolic benefits, integration into lifestyle programs, and market education on FDA-approved, minimally invasive options. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by clinical trials, strategic partnerships, and reimbursement-backed hybrid therapies.

Market Outlook and Opportunities: The Global weight-loss devices market is at a tipping point, driven by obesity epidemic mandates and every ounce of technological evolution in metabolic extracts. Valued at USD 3.6 billion in 2023, it is projected to reach USD 5.6 billion by 2031 at a steady 8.5% CAGR. North America, capturing nearly half the global share, spearheads expansion powered by healthcare demand, while Asia Pacific benefits from rising incomes. Progress in bioresorbable sourcing and enhanced implantation align with FDA safety aims, although hurdles like cost barriers, awareness gaps, and procedural limits remain. Post-pandemic focus on preventive wellness and rising embrace of telehealth coaching unlock vast potential for BMI management and comorbidity reduction in clinics, hospitals, and home sectors.

Related Reports:

Bariatric Surgery Devices Market -
https://www.datamintelligence.com/research-report/bariatric-surgery-devices-market?Nitin

Wearable Fitness Devices Market -
https://www.datamintelligence.com/research-report/wearable-fitness-devices-market?Nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.